Orasis Pharmaceuticals
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
3
Funding Rounds
$111.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company Orasis Pharmaceuticals has raised a total of $81m in funding over 3 rounds.
Key Insights:
- Orasis Pharmaceuticals October 2024 Series D Funding Round: $68m
- Orasis Pharma Series B round, June 2018: $13m
- Orasis Pharma Series C round September 2020: $30m
Orasis Pharmaceuticals October 2024 Series D Funding Round
$68m
Orasis Pharma Series B round, June 2018
$13m
Orasis Pharma Series C round September 2020
$30m
Industries
Orasis Pharmaceuticals is active in the following industries: